Junli He insider trades
Open-market stock purchases and sales by Junli He, CEO at Harvard Apparatus Regenerative Technology, Inc, from SEC Form 4 filings since Sep 5, 2021.
Track record: 0% of 13 scored buys are up 5% or more since purchase, averaging -63%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Nov 25, 2025 | HRGN Harvard Apparatus Regenerative Technology, Inc | Bought | $5.1K |